LV14878A - A method for papillary thyroid cancer risk assessment in patients with thyroid nodules - Google Patents

A method for papillary thyroid cancer risk assessment in patients with thyroid nodules

Info

Publication number
LV14878A
LV14878A LVP-14-20A LV140020A LV14878A LV 14878 A LV14878 A LV 14878A LV 140020 A LV140020 A LV 140020A LV 14878 A LV14878 A LV 14878A
Authority
LV
Latvia
Prior art keywords
patients
risk assessment
cancer risk
thyroid
nodules
Prior art date
Application number
LVP-14-20A
Other languages
Latvian (lv)
Other versions
LV14878B (en
Inventor
Artūrs OZOLIŅŠ
Jānis Gardovskis
Zenons NARBUTS
Kaspars STEPANOVS
Pēteris Priedītis
Original Assignee
Rīgas Stradiņa Universitāte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rīgas Stradiņa Universitāte filed Critical Rīgas Stradiņa Universitāte
Priority to LVP-14-20A priority Critical patent/LV14878B/en
Publication of LV14878A publication Critical patent/LV14878A/en
Publication of LV14878B publication Critical patent/LV14878B/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to endocrinology and genetic investigation methods. A method for assessment of papillary thyroid cancer risk in patients with thyroid nodules is provided for. The method comprises detection of biomarker HBME-1. High risk of develpoment of papillary thyroid cancer is assessed when expression of HBME-1 is 2.68 or higher.
LVP-14-20A 2014-02-25 2014-02-25 A method for papillary thyroid cancer risk assessment in patients with thyroid nodules LV14878B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LVP-14-20A LV14878B (en) 2014-02-25 2014-02-25 A method for papillary thyroid cancer risk assessment in patients with thyroid nodules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-14-20A LV14878B (en) 2014-02-25 2014-02-25 A method for papillary thyroid cancer risk assessment in patients with thyroid nodules

Publications (2)

Publication Number Publication Date
LV14878A true LV14878A (en) 2014-06-20
LV14878B LV14878B (en) 2014-10-20

Family

ID=50941955

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-14-20A LV14878B (en) 2014-02-25 2014-02-25 A method for papillary thyroid cancer risk assessment in patients with thyroid nodules

Country Status (1)

Country Link
LV (1) LV14878B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115792247A (en) * 2023-02-09 2023-03-14 杭州市第一人民医院 Application of protein combination in preparation of papillary thyroid carcinoma risk auxiliary layering system

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115792247A (en) * 2023-02-09 2023-03-14 杭州市第一人民医院 Application of protein combination in preparation of papillary thyroid carcinoma risk auxiliary layering system
CN115792247B (en) * 2023-02-09 2023-09-15 杭州市第一人民医院 Application of protein combination in preparation of thyroid papillary carcinoma risk auxiliary layering system

Also Published As

Publication number Publication date
LV14878B (en) 2014-10-20

Similar Documents

Publication Publication Date Title
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
NZ731467A (en) Anti-tim3 antibodies and methods of use
EP3170094A4 (en) Method and system for robust tagging of named entities in the presence of source or translation errors
MX2017003933A (en) Methods of treating liver disease.
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
MX369067B (en) Method for reducing total gas production and/or methane production in a ruminant animal.
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
MY188799A (en) Anti-cd79b antibodies and methods of use
PH12017500293A1 (en) Boronic acid derivatives
SG10201804505VA (en) Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
MX2017004043A (en) Boronic acid derivatives.
MX2017004037A (en) Boronic acid derivatives.
MX2016009858A (en) Anti-pcsk9~glp-1 fusions and methods for use.
MX2016004865A (en) Social relationship analysis method and device.
EP3161650A4 (en) Method and apparatus of usb 3.1 retimer presence detect and index
MX2016009590A (en) Apilimod compositions and methods for using same.
MX2017004046A (en) Boronic acid derivatives.
MX2019006005A (en) Methods for cancer detection.
GB201621403D0 (en) Data processing system and method for financial or non-financial data
SG11201609677WA (en) Method for reducing the chlorine content of organomonophosphites using dimethylaminobutane, triethylamine or triethanolamine
MX2016015163A (en) Mit biomarkers and methods using the same.
EP3145516A4 (en) Methods and compositions for treating malignancies with dendritic cells
BR112017006593A2 (en) method to detect ovarian cancer
EA201891478A1 (en) METHODS AND COMPOSITIONS FOR RISK ASSESSMENT FOR CANCER
GB201502289D0 (en) Methods and systems for analyzing financial dataset